Sign In to Follow Application
View All Documents & Correspondence

Compositions And Methods For Diagnosing And Treatng Asthma Or Other Allergic Or Inflammatory Diseases

Abstract: The present invention provides compositions and methods useful for detecting or treating asthma or other allergic or inflammatory diseases. In one aspect, the methods of the present invention include inhibiting the activity or expression of a component of an arginine metabolic pathway in tissues affected by asthma or other allergic or inflammatory diseases. In many embodiments, the component being inhibited is a cationic amino acid transporter, an arginase, or a component downstream of the arg nase. In many other embodiments, the activity or expression of the component is i bited by an agent that binds to the component. In still many other embodiments, the activity or expression of the component is inhibited by an agent that binds a polynucleotide encoding the component.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
04 December 2007
Publication Number
07/2008
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

WYETH
5 GIRALDA FARMS, MADISON, NEW JERSEY

Inventors

1. BOWMAN MICHAEL R
63 GLOUCESTER ROAD, WESTWOOD, MA 02090
2. ELLIS DEBRA
1266 PAWTUCKET BOULEVARD, LOWELL, MA 01854
3. FOLLETTIE MAXIMILLIAN T
12 GREENSBROOK WAY, BELMONT, WA 02478
4. WINKLER AARON
151 MARY STREET, ARLINGTON, MA 02474
5. WILLIAMS CARA
11 OBSERVATORY ROAD, METHUEN, MA 01844
6. CHEN HENG
129 NORTH STREET, #8, NEWTON, MA 02460
7. LIU WEI
73 BLACKMER ROAD, SUDBURY, MA 01776

Specification

The present invention provides compositions and methods useful for detecting or treating asthma or other allergic
or inflammatory diseases. In one aspect, the methods of the present invention include inhibiting the activity or expression of a
component of an arginine metabolic pathway in tissues affected by asthma or other allergic or inflammatory diseases. In many
embodiments, the component being inhibited is a cationic amino acid transporter, an arginase, or a component downstream of the
arg nase. In many other embodiments, the activity or expression of the component is i bited by an agent that binds to the component.
In still many other embodiments, the activity or expression of the component is inhibited by an agent that binds a polynucleotide
encoding the component.

Documents

Application Documents

# Name Date
1 4697-KOLNP-2007-PRIORITY DOCUMENT.pdf 2011-10-08
1 ABANDONED LETTER.pdf 2016-12-05
2 4697-KOLNP-2007-FORM 3 1.1.pdf 2011-10-08
2 FIRST EXAMINATION REPORT.pdf 2016-12-05
3 4697-kolnp-2007-form 18.pdf 2011-10-08
3 4697-KOLNP-2007-ABANDONED LETTER.pdf 2016-10-05
4 4697-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2016-10-05
4 4697-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf 2011-10-08
5 4697-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
5 4697-KOLNP-2007-ASSIGNMENT.pdf 2011-10-08
6 04697-kolnp-2007-sequence listing.pdf 2011-10-08
6 04697-kolnp-2007-abstract.pdf 2011-10-08
7 04697-kolnp-2007-gpa.pdf 2011-10-08
7 04697-kolnp-2007-claims.pdf 2011-10-08
8 04697-kolnp-2007-form 5.pdf 2011-10-08
8 04697-kolnp-2007-correspondence others.pdf 2011-10-08
9 04697-kolnp-2007-description complete.pdf 2011-10-08
9 04697-kolnp-2007-form 3.pdf 2011-10-08
10 04697-kolnp-2007-drawings.pdf 2011-10-08
10 04697-kolnp-2007-form 2.pdf 2011-10-08
11 04697-kolnp-2007-form 1.pdf 2011-10-08
12 04697-kolnp-2007-drawings.pdf 2011-10-08
12 04697-kolnp-2007-form 2.pdf 2011-10-08
13 04697-kolnp-2007-description complete.pdf 2011-10-08
13 04697-kolnp-2007-form 3.pdf 2011-10-08
14 04697-kolnp-2007-correspondence others.pdf 2011-10-08
14 04697-kolnp-2007-form 5.pdf 2011-10-08
15 04697-kolnp-2007-claims.pdf 2011-10-08
15 04697-kolnp-2007-gpa.pdf 2011-10-08
16 04697-kolnp-2007-abstract.pdf 2011-10-08
16 04697-kolnp-2007-sequence listing.pdf 2011-10-08
17 4697-KOLNP-2007-ASSIGNMENT.pdf 2011-10-08
17 4697-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
18 4697-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf 2011-10-08
18 4697-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2016-10-05
19 4697-kolnp-2007-form 18.pdf 2011-10-08
19 4697-KOLNP-2007-ABANDONED LETTER.pdf 2016-10-05
20 FIRST EXAMINATION REPORT.pdf 2016-12-05
20 4697-KOLNP-2007-FORM 3 1.1.pdf 2011-10-08
21 ABANDONED LETTER.pdf 2016-12-05
21 4697-KOLNP-2007-PRIORITY DOCUMENT.pdf 2011-10-08